Cerebral analgesic response to nonsteroidal anti-inflammatory drug ibuprofen

Pain

Volumn 156, Issue 7, 2015, Pages 1301-1310

  Hodkinson, Duncan J ^a,b   Khawaja, Nadine ^c   O'Daly, Owen ^a   Thacker, Michael A ^a   Zelaya, Fernando O ^a   Wooldridge, Caroline L ^a   Renton, Tara F ^c   Williams, Steven C R ^a   Howard, Matthew A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesia; ASL; CBF; COX; Ibuprofen; Imaging; NSAID

Indexed keywords

IBUPROFEN; PLACEBO; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SPIN LABELING;

ADULT; ANALGESIA; ANTINOCICEPTION; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HUMAN; MALE; MOLAR TOOTH; NERVE CELL NETWORK; NEUROMODULATION; NUCLEAR MAGNETIC RESONANCE SCANNER; OPEN STUDY; PAIN ASSESSMENT; PAIN MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SPIN LABELING; TOOTH EXTRACTION; TREATMENT RESPONSE; VISUAL ANALOG SCALE; ADVERSE EFFECTS; BRAIN; BRAIN CIRCULATION; DRUG EFFECTS; METABOLISM; PAIN, POSTOPERATIVE; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; HUMANS; IBUPROFEN; MALE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; SPIN LABELS; TOOTH EXTRACTION; YOUNG ADULT;

EID: 84945305169     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000176     Document Type: Article

References (80)

1. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53.
2. Aguirre GK, Detre JA, Zarahn E, Alsop DC. Experimental design and the relative sensitivity of BOLD and perfusion fMRI. NeuroImage 2002;15: 488-500.
3. Amanzio M, Pollo A, Maggi G, Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. PAIN 2001;90:205-15.
4. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005;9:463-84.
5. Atlas LY, Wager TD. How expectations shape pain. Neurosci Lett 2012; 520:140-8.
6. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 2010;468: 232-43.
7. Barden J, Edwards JE, McQuay HJ, Andrew Moore R. Pain and analgesic response after third molar extraction and other postsurgical pain. PAIN 2004;107:86-90.
8. Beissner F, Meissner K, Bar KJ, Napadow V. The autonomic brain: an activation likelihood estimation meta-analysis for central processing of autonomic function. J Neurosci 2013;33:10503-11.
9. Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clinic Proc 1993;68:988-1001.
10. Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013;93:1207-46.
11. Bernareggi A. The pharmacokinetic profile of nimesulide in healthy volunteers. Drugs 1993;46(suppl 1):64-72.
12. Bingel U, Tracey I. Imaging CNS modulation of pain in humans. Physiology (Bethesda) 2008;23:371-80.
13. Borsook D, Edwards R, Elman I, Becerra L, Levine J. Pain and analgesia: the value of salience circuits. Prog Neurobiol 2013;104:93-105.
14. Cechetto DF, Chen SJ. Subcortical sites mediating sympathetic responses from insular cortex in rats. Am J Physiol 1990;258: R245-255.
15. Chen L, Yang G, Grosser T. Prostanoids and inflammatory pain. Prostaglandins Other Lipid Mediat 2013;104-105:58-66.
16. Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 2005;6:545-52.
17. Cooper SA, Beaver WT. A model to evaluate mild analgesics in oral surgery outpatients. Clin Pharmacol Ther 1976;20:241-50.
18. Cooper SA, Desjardins PJ. The value of the dental impaction pain model in drug development. Methods Mol Biol 2010;617:175-90.
19. Courad JP, Besse D, Delchambre C, Hanoun N, Hamon M, Eschalier A, Caussade F, Cloarec A. Acetaminophen distribution in the rat central nervous system. Life Sci 2001;69:1455-64.
20. Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 2003;13:500-5.
21. Craig AD. A new view of pain as a homeostatic emotion. Trends Neurosci 2003;26:303-7.
22. Critchley HD, Harrison NA. Visceral influences on brain and behavior. Neuron 2013;77:624-38.
23. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-97.
24. Dawes J, Andersson D, Bennett D, Bevin S, McMahon S. Inflammatory mediators and modulators of pain. In:McMahon S, Koltzenburg M, Tracey I, Turk D, editors.Wall andMelzack's textbook of pain: Saunders, USA, 2013.
25. Day RO, Brooks PM. Variations in response to non-steroidal antiinflammatory drugs. Br J Clin Pharmacol 1987;23:655-8.
26. Day RO, McLachlan AJ, Graham GG, Williams KM. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1999;36:191-210.
27. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane database Syst Rev 2009; (3):CD001548.
28. Dirig DM, Isakson PC, Yaksh TL. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 1998;285:1031-8.
29. Downar J, Crawley AP, Mikulis DJ, Davis KD. A multimodal cortical network for the detection of changes in the sensory environment. Nat Neurosci 2000;3:277-83.
30. Downar J, Mikulis DJ, Davis KD. Neural correlates of the prolonged salience of painful stimulation. Neuroimage 2003;20:1540-51.
31. Dubner R, Ren K. Brainstem mechanisms of persistent pain following injury. J Orofacial Pain 2004;18:299-305.
32. Eisenach JC, Curry R, Rauck R, Pan P, Yaksh TL. Role of spinal cyclooxygenase in human postoperative and chronic pain. Anesthesiology 2010;112:1225-33.
33. Eisenach JC, Curry R, Tong C, Houle TT, Yaksh TL. Effects of intrathecal ketorolac on human experimental pain. Anesthesiology 2010;112: 1216-24.
34. Favilla S, Huber A, Pagnoni G, Lui F, Facchin P, Cocchi M, Baraldi P, Porro CA. Ranking brain areas encoding the perceived level of pain from fMRI data. Neuroimage 2014;90:153-62.
35. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 2004; 5:565-75.
36. Fisher SE, Frame JW, Rout PG, McEntegart DJ. Factors affecting the onset and severity of pain following the surgical removal of unilateral impacted mandibular third molar teeth. Br dental J 1988;164:351-4.
37. Hargreaves KM. Orofacial pain. PAIN 2011;152(3 suppl):S25-32.
38. Hodkinson DJ, Krause K, Khawaja N, Renton TF, Huggins JP, Vennart W, Thacker MA, Mehta MA, Zelaya FO,Williams SC, Howard MA. Quantifying the test-retest reliability of cerebral blood flow measurements in a clinical model of on-going post-surgical pain: a study using pseudo-continuous arterial spin labelling. Neuroimage Clin 2013;3:301-10.
39. Hodkinson DJ, O'Daly O, Zunszain PA, Pariante CM, Lazurenko V, Zelaya FO, Howard MA, Williams SC. Circadian and homeostatic modulation of functional connectivity and regional cerebral blood flow in humans under normal entrained conditions. J Cereb Blood flow Metab 2014;34(9): 1493-9.
40. Howard MA, Krause K, Khawaja N, Massat N, Zelaya F, Schumann G, Huggins JP, Vennart W, Williams SC, Renton TF. Beyond patient reported pain: perfusion magnetic resonance imaging demonstrates reproducible cerebral representation of ongoing post-surgical pain. PLoS One 2011;6: e17096.
41. Huber JD, Witt KA, Hom S, Egleton RD, Mark KS, Davis TP. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart circulatory Physiol 2001;280:H1241-8.
42. Juhl GI, Jensen TS, Norholt SE, Svensson P. Central sensitization phenomena after third molar surgery: a quantitative sensory testing study. Eur J Pain 2008;12:116-27.
43. Kirsch I. The response set theory of hypnosis: expectancy and physiology. Am J Clin Hypn 2001;44:69-73.
44. Kirtikara K, Swangkul S, Ballou LR. The analysis of nonsteroidal antiinflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells. Inflamm Res 2001;50:327-32.
45. Klinger R, Soost S, Flor H, Worm M. Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. PAIN 2007; 128:31-9.
46. Kucyi A, Salomons TV, Davis KD. Mind wandering away from pain dynamically engages antinociceptive and default mode brain networks. Proc Natl Acad Sci U S A 2013;110:18692-7.
47. Legrain V, Iannetti GD, Plaghki L, Mouraux A. The pain matrix reloaded: a salience detection system for the body. Prog Neurobiol 2011;93: 111-24.
48. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978;2:654-7.
49. Lorenz J, Cross DJ, Minoshima S, Morrow TJ, Paulson PE, Casey KL. A unique representation of heat allodynia in the human brain. Neuron 2002; 35:383-93.
50. Mason P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu Rev Neurosci 2001;24:737-77.
51. McCormack K, Brune K. Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs 1991;41:533-47.
52. Millan MJ. Descending control of pain. Prog Neurobiol 2002;66:355-474.
53. Minami T, Nakano H, Kobayashi T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Ito S. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 2001;133:438-44.
54. Mouraux A, Diukova A, Lee MC, Wise RG, Iannetti GD. A multisensory investigation of the functional significance of the pain matrix. NeuroImage 2011;54:2237-49.
55. Navratilova E, Porreca F. Reward and motivation in pain and pain relief. Nat Neurosci 2014;17:1304-12.
56. NICE/NHS. Technology Appraisal Guidance No.1 Guidelines for the Extraction of Wisdom Teeth. London: National Institute for Clinical Excellence, 2000.
57. O'Muircheartaigh J, Marquand A, Hodkinson DJ, Krause K, Khawaja N, Renton TF, Huggins JP, Vennart W, Williams SC, Howard MA. Multivariate decoding of cerebral blood flow measures in a clinical model of on-going postsurgical pain. Hum Brain Mapp 2015;36:633-42.
58. Parepally JM, Mandula H, Smith QR. Brain uptake of nonsteroidal antiinflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm Res 2006;23:873-81.
59. Pogatzki-Zahn EM, Wagner C, Meinhardt-Renner A, Burgmer M, Beste C, Zahn PK, Pfleiderer B. Coding of incisional pain in the brain: a functional magnetic resonance imaging study in human volunteers. Anesthesiology 2010;112:406-17.
60. Renton T, Smeeton N, McGurk M. Factors predictive of difficulty of mandibular third molar surgery. Br dental J 2001;190:607-10.
61. Salimi-Khorshidi G, Smith SM, Nichols TE. Adjusting the effect of nonstationarity in cluster-based and TFCE inference. NeuroImage 2011; 54:2006-19.
62. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-5.
63. Saper CB. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci 2002; 25:433-69.
64. Schlereth T, Birklein F. The sympathetic nervous system and pain. Neuromolecular Med 2008;10:141-7.
65. Sessle BJ. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 2000;11:57-91.
66. Sessle BJ. Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 2011;97:179-206.
67. Seymour RA, Frame J, Negus TW, Hawkesford JE, Marsden J, Matthew IR. The comparative efficacy of aceclofenac and ibuprofen in postoperative pain after third molar surgery. Br J Oral Maxill Surg 1998;36:375-9.
68. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009;44:83-98.
69. Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isozymes-1 and-2with NSAIDs. Ann New York Acad Sci 1994;744:50-7.
70. Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull 2004;130:324-40.
71. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenaseprostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002;42:553-83.
72. Teepker M, Peters M, Vedder H, Schepelmann K, Lautenbacher S. Menstrual variation in experimental pain: correlation with gonadal hormones. Neuropsychobiology 2010;61:131-40.
73. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010;16:1277-83.
74. Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 2007;55:377-91.
75. Verberne AJ, Owens NC. Cortical modulation of the cardiovascular system. Prog Neurobiol 1998;54:149-68.
76. Vincent K, Tracey I. Sex hormones and pain: the evidence from functional imaging. Curr Pain Headache Rep 2010;14:396-403.
77. Wager TD,Atlas LY,LindquistMA,RoyM,WooCW,KrossE.An fMRI-based neurologic signature of physical pain. New Engl J Med 2013;368:1388-97.
78. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. PAIN 2011;152(3 suppl):S2-15.
79. Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 2001;95:241-9.
80. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001;21:5847-53.